Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients

被引：49

作者：

Keung, Benison ^{[1
]}

Robeson, Kimberly R. ^{[1
]}

DiCapua, Daniel B. ^{[1
]}

Rosen, Jennifer B. ^{[1
]}

O'Connor, Kevin C. ^{[1
]}

Goldstein, Jonathan M. ^{[1
]}

Nowak, Richard J. ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2013年 / 84卷 / 12期

关键词：

D O I：

10.1136/jnnp-2012-303664

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1407 / +

页数：3

共 9 条

[1] Standards of measurements in myasthenia gravis [J].

Barohn, RJ .

MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :432-439

[2] Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project [J].

Carson, Kenneth R. ;

Evens, Andrew M. ;

Richey, Elizabeth A. ;

Habermann, Thomas M. ;

Focosi, Daniele ;

Seymour, John F. ;

Laubach, Jacob ;

Bawn, Susie D. ;

Gordon, Leo I. ;

Winter, Jane N. ;

Furman, Richard R. ;

Vose, Julie M. ;

Zelenetz, Andrew D. ;

Mamtani, Ronac ;

Raisch, Dennis W. ;

Dorshimer, Gary W. ;

Rosen, Steven T. ;

Muro, Kenji ;

Gottardi-Littell, Numa R. ;

Talley, Robert L. ;

Sartor, Oliver ;

Green, David ;

Major, Eugene O. ;

Bennett, Charles L. .

BLOOD, 2009, 113 (20) :4834-4840

[3] Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study [J].

Collongues, Nicolas ;

Casez, Olivier ;

Lacour, Arnaud ;

Tranchant, Christine ;

Vermersch, Patrick ;

de Seze, Jerome ;

Lebrun, Christine .

MUSCLE & NERVE, 2012, 46 (05) :687-691

[4] Long-lasting treatment effect of rituximab in MuSK myasthenia [J].

Diaz-Manera, J. ;

Martinez-Hernandez, E. ;

Querol, L. ;

Klooster, R. ;

Rojas-Garcia, R. ;

Suarez-Calvet, X. ;

Munoz-Blanco, J. L. ;

Mazia, C. ;

Straasheijm, K. R. ;

Gallardo, E. ;

Juarez, C. ;

Verschuuren, J. J. ;

Illa, I. .

NEUROLOGY, 2012, 78 (03) :189-193

[5] Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients [J].

Illa, Isabel ;

Diaz-Manera, Jordi ;

Rojas-Garcia, Ricard ;

Pradas, Jesus ;

Rey, Antonio ;

Blesa, Rafael ;

Juarez, Candido ;

Gallardo, Eduard .

JOURNAL OF NEUROIMMUNOLOGY, 2008, 201 :90-94

[6] Successful treatment of refractory generalized myasthenia gravis with rituximab [J].

Lebrun, C. ;

Bourg, V. ;

Tieulie, N. ;

Thomas, P. .

EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (02) :246-250

[7] The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome [J].

Maddison, Paul ;

McConville, John ;

Farrugia, Maria Elena ;

Davies, Nicholas ;

Rose, Michael ;

Norwood, Fiona ;

Jungbluth, Heinz ;

Robb, Stephanie ;

Hilton-Jones, David .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (06) :671-673

[8]

Nowak Richard J, 2011, Ther Adv Neurol Disord, V4, P259, DOI 10.1177/1756285611411503

[9] Clinical phenotype of muscle-specific tyrosine kinase-antibody positive myasthenia gravis [J].

Wolfe, Gil I. ;

Oh, Shin J. .

MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE, 2008, 1132 :71-75

← 1 →